The Medical Affairs and Regulatory team at Roivant Sciences is responsible for ensuring the successful development and regulatory approval of the company's biopharmaceutical products. This team collaborates with cross-functional leaders to provide medical insights, oversee clinical trial design and execution, and communicate with regulatory bodies, ensuring compliance and alignment with industry standards. Their ultimate goal is to facilitate safe and effective treatments that enhance patient outcomes.
Ahmet Tutuncu
EVP, Clinical & Regulatory, Re...
Bill Macias
Chief Medical Officer, Immunov...
David Rubenstein
Chief Scientific Officer, Derm...
Deya Corzo
Chief Medical Officer-In-Resid...
Gaston Picchio
Chief Development Officer, Arb...
James Heyes
Chief Scientific Officer, Gene...
Joseph McIntosh
Chief Medical Officer, Aruvant
Michael J. Elliot
Chief Scientific Officer, Immu...
Min Lin
Senior Director, Biostatistics
Philip Brown
Chief Medical Officer, Dermava...
View all